jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa. The company's therapy used retinal progenitor cells can secrete growth factors to rescue damaged retinal cells which help in treating a degenerative eye disease that ultimately causes blindness enabling, patients afflicted by conditions that lead to blindness,